Executive Vice Chair, Department of Diagnostic, Molecular, and Interventional Radiology Mount Sinai Health System
New York, NY
Joined April 2013
- Tweets3.4K
- Following791
- Followers6.1K
- Likes2.4K
Pinned Tweet
I ask my professional contacts and colleagues to follow this model. Please block all anonymous accounts. The tone of these accounts has become increasing aggressive and harmful. They do not deserve your attention. If you follow, you are endorsing this behavior on #medtwitter
Robert A Lookstein MD, MHCDL retweeted
Congratulations to Dr. George Dangas (left) and Dr. Robert Lookstein (right) for being recognized at the @American_Heart Scientific Sessions 2026.
Dr. @georgedangas received Laennec Master Clinician Award, honoring a lifetime achievement in patient care and teaching in cardiology.
Dr. @roblookstein received the James T. Willerson Award in Clinical Science from the journal Circulation, recognizing the best clinical science paper published in the journal during the previous 12 months.
@AHAScience @MountSinaiHeart
#ScientificSessions26 #Cardiology #CarioX
Honored to receive the 2026 James T Willerson Award from @CircAHA at @AHAScience. The award is accepted on behalf of everyone who contributed to #STORM-PE trial including my Global Co-PI @RosovskyRachel, the steering committee, and our trial sites. @PenVascular @PERTConsortium
Robert A Lookstein MD, MHCDL retweeted
Congratulations to Dr. Robert Lookstein on receiving the James T. Willerson Award in Clinical Science at the @American_Heart in Chicago! A well-deserved recognition of his outstanding contributions to pulmonary embolism (PE) treatment. 👏🏆
Publication Alert! Safety and Effectiveness of the GORE VIABAHN FORTEGRA Venous Stent for the Treatment of Symptomatic Inferior Vena Cava Obstruction With or Without Combined Iliofemoral Obstruction - European Journal of Vascular and Endovascular Surgery ejves.com/article/S1078-5884…
Robert A Lookstein MD, MHCDL retweeted
Whether you're interested in research, technology, or patient outcomes, Dr. @roblookstein's sessions at #TCT2026 are not to be missed.
@TCTConference @CRFHeart @IcahnMountSinai
#CardioX #Cardiology
Robert A Lookstein MD, MHCDL retweeted
Registration is officially OPEN for CARVE 2027! 🎉
Join us February 14-17, 2027, at the Viewline Resort Snowmass for the 19th Annual CARVE Conference, presented by The VIVA Foundation.
We look forward to seeing you in Snowmass!
Register here: carve-cme.com/
Robert A Lookstein MD, MHCDL retweeted
Over at the ACIR Annual Meeting, SIR President @saherssabri
is talking about the Value of IR.
Robert A Lookstein, MD, FSIR, FSVM Top 10 Advances in Pulmonary Embolism youtu.be/0JiNxds3i6g?si=zawS… via @YouTube
Robert A Lookstein MD, MHCDL retweeted
What’s changing in VTE care? Hear Dr. Vedantham, Dr. Muck, Dr. Lookstein, Dr. Secemsky, and Dr. Mouawad at ISET 2027. Explore evidence shaping treatment decisions and bring your questions: hubs.ly/Q04BQk0l0
@roblookstein @EricSecemskyMD @NickMouawadMD
Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-High Risk PE: Improved Functional 90-Day Outcomes in STORM-PE RCT | JACC: Cardiovascular Interventions jacc.org/doi/10.1016/j.jcin.…
Wearable Device Data Shows Correlation Between Clinical Assessments, Real-world Functional Recovery in Patients with Pulmonary Embolism dicardiology.com/content/wea…
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism biospace.com/press-releases/…
5
420
New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured... prn.to/4hVhgUb
Real-world data highlight the benefits of thrombectomy for pulmonary embolism patients cardiovascularbusiness.com/t…
STORM-PE RCT 90 day Outcomes:
The First RCT of Mechanical Thrombectomy for Acute Pulm Embolism to demonstrate a functional benefit for Endovascular Treatment at 90 day follow up...
Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-H... sciencedirect.com/science/ar…
Robert A Lookstein MD, MHCDL retweeted
Innova’s Laguna Thrombectomy System Evaluated in TRUST Pivotal Study for PE Indication | Presented at #VIVA26
evtoday.com/news/innovas-lag…
Robert A Lookstein MD, MHCDL retweeted
STORM-PE and STRIKE-PE Data Presented for Penumbra’s CAVT for Pulmonary Embolism | Presented at #VIVA26 | @penumbrainc
evtoday.com/news/storm-pe-an…
Publication Alert!!! @RosovskyRachel and the entire #STORM-PE team: 90 day functional data for #CAVT
Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-H... sciencedirect.com/science/ar…